3 New Strong Buy Ratings from Top-Rated Analysts: 08/19/2025

Need some stock ideas today? Here are some recent highlights from our most-visited screener: 

• Why analysts are confident Eli Lilly (LLY) still has room to grow 
• Utility-scale solar projects are in demand — and it’s benefiting Array Technologies (ARRY) 
• Kontoor Brands (KTB) gets a noteworthy price target increase from a top-rated analyst

P.S. Get more alerts like this daily … Try WallStreetZen Premium.

A note from our sponsors...
Hurry! Enter these 2 trades by EOD Tuesday  

The man behind THIS plan has used an odd twist on trading options for the past 20 years to rack up incredible profits... even using it personally to retire in just 10 years...with a $5.3 million "nest egg" that helped him sail worry-free through every Financial Crisis and market crash since... And now he's about to release his latest two trades...  

Click here to access your first two trades.

1. Array Technologies (NASDAQ: ARRY) 

Based in New Mexico, Array Technologies is a leading provider of solar tracking systems that help maximize the efficiency of utility-scale solar projects. Wall Street analysts are quite bullish on ARRY, particularly after the company delivered a double beat in its latest quarterly report. The business enjoys a strong balance sheet, and the Treasury Department’s recent decision to largely preserve tax credits for renewable projects presents a bullish medium-term catalyst.

Zen Rating: A (Strong Buy) — see full analysis >  

Recent Price: $7.62 — get current quote > 

Max 1-year forecast: $13.00

Why we’re watching:

• At present, 13 Wall Street analysts issue ratings for Array Technologies stock. Their coverage is split between 7 Strong Buy ratings, 1 Buy rating, and 5 Hold ratings. See the ratings
• Moreover, the average 12-month price forecast for ARRY shares, currently pegged at $9.19, implies a hefty 20.63% upside.
• UBS researcher Jon Windham maintained a Strong Buy rating on Array Technologies stock after the company reported its Q2 2025 earnings, and increased his price target from $8.50 to $9.
• Looking ahead, Windham noted that management's FY 2025 guidance suggests better gross margins in 2H than in 1H.
• Our proprietary quant rating system uses 115 factors to evaluate stocks. It keeps track of roughly 4,600 equities — and ARRY ranks in the top 3%, giving it a Zen Rating of A, which has historically corresponded to an average annualized return of 32.52%.
• Each Zen Rating is a composite score of seven Component Grade ratings. For instance, Array Technologies ranks in the top 21% when it comes to Sentiment.
• In terms of Financnials, ARRY ranks in the 82nd percentile of the equities that we track.
• However, Growth is Array Technologies’ strongest suit — in this category, the stock ranks in the top 1%.  (See all 7 Zen Component Grades here >)

2. Eli Lilly (NYSE: LLY) 

Eli Lilly is a bona fide pharma powerhouse. As one of the primary beneficiaries of the weight loss drug boom, the company has seen a significant increase in stock price — and although recent news surrounding an oral product fell short of expectations, Wall Street remains confident that there’s plenty of room for LLY to rally further.

Zen Rating: B (Buy) — see full analysis >  

Recent Price: $701.23 — get current quote > 

Max 1-year forecast: $1,135.00 

Why we’re watching:

• Analyst coverage of LLY is both broad and almost unanimously positive — the stock currently has 8 Strong Buy ratings and 1 Sell rating. See the ratings
• In addition, the average price target for Eli Lilly shares, currently at $935.33, implies a hefty 33.38% upside.
• Carter Gould of Cantor Fitzgerald (a top 15% rated analyst) reiterated a Strong Buy rating on the stock after the company reported its Q2 2025 earnings on 2025/08/07, but cut his price forecast from $975 to $825.
• Gould said the launch-related "show-me-story" the company is facing was caused by orforglipron Phase 3 obesity data that fell short of expectations and semaglutide benchmarks. 
• A "resolution" might not come until late 2026, the analyst said.
• LLY is currently the 4th highest-rated stock in the General Drug Manufacturer industry, which has an Industry Rating of A.
• Eli Lilly shares rank in the top 6% of the equities that we track, giving them a Zen Rating of B, which has historically corresponded to an average annualized return of 19.88%.
• LLY offers a very compelling mix of both Value and Growth— in terms of the former, it ranks in the top 18% of stocks, and in terms of the latter, it ranks in the top 13%.
• To boot, the pharma giant’s strong balance sheet has allowed it to rank in the 84th percentile when it comes to Financials.
• With all of that said, Sentiment is Eli Lilly’s strongest Component Grade rating — as it ranks in the top 10% in this category. (See all 7 Zen Component Grades here >)

3. Kontoor Brands (NYSE: KTB) 

Kontoor Brands owns not one, but two flagship denim labels — Wrangler and Lee. Even though recent trade disputes have had an effect on the company’s business, it still managed to deliver a double beat in Q2 of 2025. The company’s disciplined inventory management, focus on direct-to-consumer (DTC) channels, and growing popularity overseas provide solid growth prospects that are increasingly being recognized by Wall Street.

Zen Rating: A (Strong Buy) — see full analysis >  

Recent Price: $70.90 — get current quote > 

Max 1-year forecast: $99.00 

Why we’re watching:

• At present, Kontoor Brands shares have 4 Strong Buy ratings and 1 Hold rating. See the ratings
• The average 12-month price forecast for KTB stock, currently at $87.60, implies a significant 23.55% upside.,  
• UBS researcher Jay Sole (a top 4% rated analyst) doubled down on a Strong Buy rating on KTB after Kontoor Brands reported its Q2 2025 earnings. The analyst also increased his price target from $92 to a Street-high $99.
• Looking ahead, Sole opined that tariffs notwithstanding, Kontoor Brands' growth prospects remain strong, supported by "resilient" margins.
• Kontoor Brands is the 2nd highest-rated stock in the Apparel Manufacturing industry, which has an Industry Rating of B.
• KTB shares rank in the top 5% of the equities that we track based on a holistic analysis of 115 proprietary factors, giving them a Zen Rating of A.
• Kontoor Brands ranks in the top 16% of stocks when it comes to Financials.
• KTB also ranks in the top 12% of equities according to Value, as it is currently trading at a very attractive price to earnings (P/E) ratio of 15.69x.
• Finally, we have KTB’s strongest Component Grade rating — Artificial Intelligence. In this category, the stock ranks in the top 10%. This means that a neural network trained on two decades of market data has selected it as a likely outperformer. (See all 7 Zen Component Grades here >)

What to Do Next?

• 9 Special Stock Lists You Need Now >
• See All “A” Rated Stocks with +32.52% Average Annual Return >
• 2 New Stocks to Buy from Steve Reitmeister >

Want to get in touch? Email us at news@wallstreetzen.com.